Development of a Communication Protocol for Telephone Disclosure of Genetic Test Results for Cancer Predisposition
Personalized Medicine
Exome
Genetic predisposition
Cancer Prevention
DOI:
10.2196/resprot.3337
Publication Date:
2014-10-29T16:47:23Z
AUTHORS (12)
ABSTRACT
Background: Dissemination of genetic testing for disease susceptibility, one application “personalized medicine”, holds the potential to empower patients and providers through informed risk reduction prevention recommendations. Genetic has become a standard practice in cancer high-risk populations. Heightened consumer awareness “cancer genes” genes other diseases (eg, cardiovascular Alzheimer’s disease), as well burgeoning availability increasingly complex genomic tests (ie, multi-gene, whole-exome -genome sequencing), escalated interest demand assessment specialists who provide it. Increasing is expected surpass access specialists. Thus, there urgent need develop effective efficient models delivery information that comparably balance risks benefits current in-person communication.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (85)
CITATIONS (19)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....